N-(2-(1H-Tetrazol-1-yl)ethyl)-3-((4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)benzamide Hydrochloride

ID: ALA4082808

PubChem CID: 132253163

Max Phase: Preclinical

Molecular Formula: C17H17ClF3N7O2

Molecular Weight: 407.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cl.NCc1cc(Oc2cccc(C(=O)NCCn3cnnn3)c2)nc(C(F)(F)F)c1

Standard InChI:  InChI=1S/C17H16F3N7O2.ClH/c18-17(19,20)14-6-11(9-21)7-15(24-14)29-13-3-1-2-12(8-13)16(28)22-4-5-27-10-23-25-26-27;/h1-3,6-8,10H,4-5,9,21H2,(H,22,28);1H

Standard InChI Key:  ALSBOXSZNBMSCR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 31  0  0  0  0  0  0  0  0999 V2000
   40.1049   -3.2846    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   36.5785   -1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5774   -2.5524    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2922   -2.9652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0087   -2.5519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0059   -1.7213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2904   -1.3122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7187   -1.3062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4348   -1.7160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2920   -3.7903    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5774   -4.2027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8665   -3.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1524   -4.1985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1518   -5.0244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8711   -5.4369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5824   -5.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8640   -1.3127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8638   -0.4876    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.1496   -1.7254    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.1467   -0.9000    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   35.8739   -6.2619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1608   -6.6767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.5897   -6.6721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4449   -6.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7318   -6.6815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0159   -6.2713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9270   -5.4541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.1194   -5.2852    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7092   -6.0011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2633   -6.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  6  8  1  0
  8  9  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  2 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 15 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
M  END

Associated Targets(Human)

LOXL2 Tchem Lysyl oxidase homolog 2 (834 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX Tchem Lysyl oxidase (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lung (1108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 407.36Molecular Weight (Monoisotopic): 407.1318AlogP: 1.77#Rotatable Bonds: 7
Polar Surface Area: 120.84Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.84CX LogP: 1.50CX LogD: 0.05
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.61Np Likeness Score: -2.17

References

1. Rowbottom MW, Bain G, Calderon I, Lasof T, Lonergan D, Lai A, Huang F, Darlington J, Prodanovich P, Santini AM, King CD, Goulet L, Shannon KE, Ma GL, Nguyen K, MacKenna DA, Evans JF, Hutchinson JH..  (2017)  Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).,  60  (10): [PMID:28471663] [10.1021/acs.jmedchem.7b00345]
2.  (2017)  Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof,